TFDA Medical Device Registration Agent Taiwan
Enter one of Asia Pacific's most advanced medtech markets and built on world class hospitals and a fast aging population. NexorTest delivers end-to-end TFDA registration: Class I/II/III & IVD product licensing, QSD (Taiwan GMP) approval, the TCP III abbreviated fast track, independent Taiwan Agent representation, and SaMD/AI compliance all under one expert roof.
Three Risk Based Device Classes Under Taiwan's Medical Devices Act
The TFDA classifies all medical devices and IVDs by risk based on intended use, invasiveness, and duration of body contact. Your class determines whether QSD is required, the documentation, fees, and review timeline.
Class I Listing Route
Designated non-sterile, non-measuring Class I devices follow a simplified listing route under Article 25 the only category where QSD is waived. Fastest path to market.
- QSD Waived
- Listing System
Class I Devices
Low risk devices such as bandages, non-powered surgical instruments, examination gloves, and basic image viewers. Light documentation burden and quick administrative review.
- 3 Months
- QSD if Sterile/Measuring
Class II Devices
Moderate risk devices including blood pressure monitors, blood glucose meters, ECG units, endoscopes, dental instruments, and many SaMD products. Requires home country approval.
- 180 Working Days
- QSD Required
- UDI Mandatory
Class III & PMA Devices
Highest risk devices such as cardiac pacemakers, implantable components, and heart valves. Devices with no Taiwan predicate are treated as PMA (new) devices requiring clinical evidence.
- Full Dossier
- Clinical Evidence
- UDI Mandatory
Choosing the Fastest Route to Your Permit License
Taiwan requires both a QSD (Taiwan GMP) approval and a product registration. Picking the right QSD mode based on your certifications and predicate availability can cut months off your timeline.
TCP III Notified Body Route
Leverage an ISO 13485 certificate issued by one of the six TFDA approved TCP III Notified Bodies (compliant with EU MDR 2017/745 / IVDR 2017/746) to qualify for the abbreviated QSD review mode the fastest way for EU certified manufacturers to satisfy Taiwan GMP.
Standard Registration with Predicate
Where a similar device is already approved in Taiwan, we cite that predicate via a Letter of Inquiry to streamline review. Class II devices with FDA/EU approval can reuse existing preclinical and test data, avoiding new testing.
New Device (PMA) Route
For devices with no Taiwan predicate, a full technical and clinical dossier is required. We design the clinical evidence and standalone performance strategy and pursue SaMD priority review for urgent or rare disease products where eligible.
Comprehensive Taiwan Regulatory Services
From classification and QSD approval through post-market surveillance, NexorTest manages every aspect of your TFDA registration and Permit License lifecycle.
TFDA Product Registration
Complete Medical Device Permit License for Class I, II, and III devices and IVDs. We manage classification, predicate search, dossier preparation, the correct submission pathway, fee payment, and query resolution end to end.
QSD (Taiwan GMP) Approval
End-to-end Quality System Documentation submissions that secure your QSD approval the GMP prerequisite for the product license. We map your ISO 13485 system to TFDA expectations and prevent the QSD interpretation gaps that stall approvals.
TCP III Abbreviated QSD
For EU certified manufacturers, we run the abbreviated QSD mode using ISO 13485 certificates from one of the six TFDA approved TCP III Notified Bodies the fastest route to satisfy Taiwan GMP and shorten your overall timeline.
Independent Taiwan Agent
Independent Local Legal Representative services. NexorTest holds your Permit License neutrally, appears on the Traditional Chinese label, manages all TFDA interactions, and lets you appoint or change distributors freely without losing control.
Predicate Search & Letter of Inquiry
We search the TFDA database for an approved predicate device and, where needed, file a Letter of Inquiry to confirm classification and similarity the decision that determines whether your device follows the standard or PMA route.
Traditional Chinese Labeling & UDI
Traditional Chinese labeling and IFU per Article 33 of the Medical Devices Act, plus UDI assignment and UDID upload for Class II and III devices preventing the labeling discrepancies that are a top cause of rejection.
IVD Registration Taiwan
In Vitro Diagnostic registration where required Class III and New IVDs undergo a two stage administrative and technical review. We handle classification, analytical and clinical performance evidence, reagent documentation, and QSD.
SaMD & AI/ML Devices
Software as a Medical Device and AI/ML strategy aligned with Taiwan's medical software classification guidance and the August 2025 CADe/CADx technical guidelines covering lifecycle, standalone performance evaluation, training data management, and priority review.
SAE Reporting, Changes & Renewals
Post-market Serious Adverse Event (SAE) reporting, change notifications, supply and flow data where designated, and license renewals keeping your QSD (3 years) and Permit License (5 years) active and compliant throughout their lifecycle.
Taiwan's Trusted TFDA Specialist
We combine a Taipei based regulatory team with TCP III and QSD expertise to deliver faster, more predictable TFDA registrations and independent Taiwan Agent representation that keeps you in control.
Taipei Based Regulatory Team
Local regulatory professionals who know the TFDA's classification database, QSD reviewers, and the Division of Medical Devices and Cosmetics first hand not an offshore desk learning the system from a distance.
TCP III & QSD Specialists
We turn your EU MDR/IVDR ISO 13485 certificate into an abbreviated QSD submission via a TFDA-approved TCP III Notified Body the fastest route to satisfy Taiwan GMP.
Independent Taiwan Agent You Keep Control
We hold your Permit License as a neutral Local Legal Representative, so you can switch or add distributors anytime without your registration being held hostage by a single commercial partner.
One Partner for APAC & Global Access
Coordinate Taiwan alongside Japan, South Korea, China NMPA, US FDA, and EU MDR/CE from a single integrated program turning one dossier into multi-market access.
Transparent Fixed Fee Packages
Our fixed fee scopes cover strategy, Taiwan Agent, QSD, dossier, submission, and post-market support, with clear milestones and deliverables.
Six Steps to Your Permit License
A proven, structured approach that minimizes TFDA deficiencies and accelerates your path to a Taiwan Medical Device Permit License.
Classification & Predicate Strategy
We confirm your TFDA risk class (I, II, or III) using the classification database, search for an approved predicate, and decide whether your device follows the standard, listing, or PMA route.
Appoint Taiwan Agent
NexorTest is appointed as your independent Taiwan Agent (Local Legal Representative), holding the required medical device firm permit and ready to hold your license and submit on your behalf.
QSD (Taiwan GMP) Approval
We prepare and submit the Quality System Documentation, using the TCP III abbreviated mode where an ISO 13485 certificate from a TFDA approved Notified Body is available to satisfy Taiwan GMP.
Dossier Preparation & Legalization
We compile the Letter of Authorization, legalized Free Sale Certificate, ISO 13485 certificate, specifications, preclinical and clinical evidence, and Traditional Chinese labeling and IFU.
TFDA Submission & Query Management
We submit to the Division of Medical Devices and Cosmetics, pay government fees, and manage every deficiency response within the one-month correction window to keep the review on track.
Permit License, UDI & Post-Market Support
You receive your 5 year Medical Device Permit License. We upload UDI to the UDID for Class II/III devices, set up SAE reporting, and manage changes and renewals before expiry.
TFDA Expertise Across Every Device Category
From implantables to AI driven digital health, our regulatory specialists cover the full breadth of medical technology entering the Taiwan market.
- 🫀 Cardiovascular & Implants
- 🧬 In Vitro Diagnostics
- 🤖 AI/ML CADe & CADx
- 💻 SaMD & Digital Health
- 🩻 Imaging & Radiology
- 🦴 Orthopaedics
- 💉 Infusion & Drug Delivery
- 🩸 Surgical Instruments
- 👁 Ophthalmics
- 🦷 Dental Devices
- 🏥 Electro-Medical Equipment
- 📱 Wearables & Remote Monitoring
Frequently Asked Questions for TFDA Medical Device Registration Taiwan
What is TFDA medical device registration in Taiwan?
TFDA registration is the mandatory market authorization issued by the Taiwan Food and Drug Administration under the Ministry of Health and Welfare. Under the Medical Devices Act (in force since May 2021), every medical device and IVD must be registered or listed before import or sale. The process covers classification (Class I, II, III), appointment of a Taiwan Agent, QSD approval that serves as Taiwan’s GMP, predicate identification, dossier preparation, and submission to the Division of Medical Devices and Cosmetics. The Permit License is valid for 5 years; QSD is typically valid around 3 years.
Do I need a Taiwan Agent to register?
Yes, Foreign manufacturers without a legal entity in Taiwan must appoint a Taiwan Agent (Local Legal Representative) as a strict prerequisite. The agent must be a Taiwan established entity holding a valid medical device firm permit, and its details appear on the Traditional Chinese label with the registration number. The agent submits the application, holds the Permit License, manages QSD, renewals and changes, and handles SAE reporting. NexorTest provides independent Taiwan Agent services so you can switch distributors freely without surrendering control of your registration.
What is QSD and is it mandatory?
Quality System Documentation (QSD) is Taiwan’s equivalent of GMP for medical devices a document based TFDA review confirming the manufacturing site’s quality system meets Taiwan’s requirements, granted as a separate approval the product license depends on. QSD is mandatory for Class I sterile, Class I measuring, Class II, and Class III devices, and waived only for designated non-sterile, non-measuring Class I products on the listing route. For foreign manufacturers the review is paper based, with no on-site inspection in most cases. EU certified manufacturers can use the TCP III abbreviated mode to expedite it.
What is the TCP III abbreviated QSD pathway?
TCP III is the third version of the TFDA EU Technical Cooperation Program. It lets manufacturers holding an ISO 13485 certificate issued by one of the six TFDA approved TCP III Notified Bodies use an abbreviated QSD review mode, significantly shortening the Taiwan GMP timeline. Eligible Notified Bodies must comply with EU MDR 2017/745 and IVDR 2017/746. For manufacturers already certified to the EU MDR or IVDR, TCP III is the fastest way to satisfy Taiwan’s QSD requirement, and is central to NexorTest’s strategy for European clients.
How long does TFDA registration take?
Timelines depend on class, QSD route, and predicate availability. Class I registration generally takes around 3 months. Class II and III review typically runs about 180 working days, and full new registrations can extend to 11-13 months once QSD, testing, or local clinical evaluation are factored in. QSD on its own can take roughly 6-10 months and usually runs concurrently with the product application, with TCP III shortening it for EU certified manufacturers. Under current rules, applicants have only one month to correct preliminary review deficiencies so our pre-submission QC is designed to prevent costly deficiency cycles.
What documents are required for TFDA registration?
Required documents include a Letter of Authorization on the TFDA template appointing the Taiwan Agent a legalized Free Sale Certificate (FSC) or CFG from the country of origin; ISO 13485 certificate and QSD documentation; product structure, materials, specifications, intended use, and drawings preclinical safety and performance reports; clinical evidence where applicable (PMA/new devices and Class III IVDs) and Traditional Chinese labeling and IFU. Class II devices approved by the US FDA or EU may reuse existing preclinical and test data. Designated Class II/III devices also require UDI submission to the UDID. NexorTest compiles, legalizes, and quality checks the full dossier.
Does Taiwan accept FDA/CE reliance?
Taiwan requires that an imported device be registered in its country of origin with a Free Sale Certificate, and home country approval is required for Class II and III before TFDA registration. Taiwan does not formally rely on FDA or CE approval to grant the license, but those approvals offer major practical advantages: Class II devices approved by the US FDA or EU can reuse existing preclinical, QC, and test documentation instead of generating new reports, and EU MDR/IVDR certification unlocks the TCP III abbreviated QSD route. We build a reliance leveraged strategy that converts your existing approvals into the fastest viable Taiwan pathway.
What is the cost of TFDA registration?
Costs combine government fees, QSD fees, professional fees, and Taiwan Agent fees. Indicative TFDA government fees are roughly USD 370 for a designated Class I listing and around USD 611 for Class I registration, with Class II/III review fees scaling with complexity and predicate availability. QSD registration fees run approximately USD 1,100 for some low risk devices up to around USD 2,200 for standard QSD applications. Professional fees depend on class, QSD route (standard vs TCP III), predicate availability, and Taiwan Agent scope. NexorTest offers transparent fixed fee packages. Contact us for a free cost assessment.
Ready to Enter the Taiwan Medical Device Market?
Get a free TFDA regulatory assessment from specialists in Taiwan market access. Our experts will map your fastest route including the TCP III abbreviated QSD pathway to a Medical Device Permit License.